August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
% EBITDA Mid-single digit growth CAPEX (exclude spectrum) Bt27–30bn (depending on Foreign Exchange Rate) Core service revenue to grow cautiously amid risks and uncertainties at 3 – 5% In 2023, the
service revenue Around 3 – 5 % EBITDA Mid-single digit growth CAPEX (exclude spectrum) Bt27–30bn (depending on Foreign Exchange Rate) Core service revenue to grow cautiously amid risks and uncertainties at
Stock Exchange of Thailand Aapico Hitech Public Company Limited (“the Company”) would like to explain the consolidated financial statements of the Company for the 1st quarter of fiscal year 2023 ended as
Profits increased 40% to THB 539m in Q2 2017 from THB 384m in Q2 2016. Net Profit increased 62% to THB 676m in Q217 from THB 417m in Q216, due to higher operating profits and exchange gain in Q217. Quarter
Profits increased 17% to THB 632m in Q3 2017 from THB 540m in Q3 2016. Net Profit increased 35% to THB 769m in Q317 from THB 569m in Q316, due to higher operating profits and exchange gain in Q317. Quarter
decreased 18% to THB 409m in Q2 2019 from THB 500m in Q2 2018. Net Profit increased 98% to THB 536m in Q219 from THB 270m in Q218, due exchange gain of 103m in Q219 vs exchange loss of 236m in Q218. Quarter
from USD 162m in Q119. The average exchange rate for Q120 was 1% stronger at THB/USD 31.3 from THB/USD 31.6 in Q119. As a result the sales revenue in THB terms decreased 10% year on year for the quarter
สรุปผลการดำเนินงานของบจ -Translation- February 13th, 2019 Subject: Management Discussion and Analysis for Quarter 1/FY2019 To: Managing Director The Stock Exchange of Thailand Inoue Rubber ( Thailand
สรุปผลการดำเนินงานของบจ -Translation- February 13th, 2018 Subject: Management Discussion and Analysis for the Quarter 1/2018 To: Managing Director The Stock Exchange of Thailand Inoue Rubber